Literature DB >> 24897826

Tuberculosis incidence in Cameroonian prisons: a 1-year prospective study.

J Noeske, N Ndi, G Amougou Elo, S Mbondi Mfondih.   

Abstract

BACKGROUND: Rates of tuberculosis (TB) transmission in prisons are reported to be high worldwide. However, a recent systematic review identified only 19 published studies reporting TB incidence in prisons, most of them from the last century and only one from sub-Saharan Africa.
OBJECTIVES: To assess the persisting risk of smear-positive pulmonary tuberculosis (PTB) among prison populations benefiting from a comprehensive TB/HIV control programme in Cameroon, compared with that in the community.
METHODS: This descriptive and prospective study evaluated PTB incidence rates over a 1-year period. The study population was inmates of 10 major prisons, sampled by convenience, comprising about 45% of the country's prison population. As PTB incident cases, all prisoners with incident PTB after a prison stay of > or = 90 days were considered. The prison TB incidence rate was compared with that of the corresponding male population in the community.
RESULTS: The mean annual PTB incidence in Cameroonian prisons in this study was 1 700 cases in 100 000 person-years at risk, the incidence rate ratio being 9.4 (95% confidence interval 8.1-10.9).
CONCLUSION: Findings suggest that internationally recommended prison TB control measures alone may not help protect prisoners from within-prison spread of TB. Imprisonment policies and conditions therefore require fundamental changes.

Entities:  

Mesh:

Year:  2014        PMID: 24897826     DOI: 10.7196/samj.7384

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  High utility of active tuberculosis case finding in an Ethiopian prison.

Authors:  Y Merid; Y Woldeamanuel; M Abebe; D G Datiko; T Hailu; G Habtamu; G Assefa; R R Kempker; H M Blumberg; A Aseffa
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 2.373

Review 2.  HIV and tuberculosis in prisons in sub-Saharan Africa.

Authors:  Lilanganee Telisinghe; Salome Charalambous; Stephanie M Topp; Michael E Herce; Christopher J Hoffmann; Peter Barron; Erik J Schouten; Andreas Jahn; Rony Zachariah; Anthony D Harries; Chris Beyrer; Joseph J Amon
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

3.  Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons.

Authors:  Katie R Maggard; Sisa Hatwiinda; Jennifer B Harris; Winifreda Phiri; Annika Krüüner; Kaunda Kaunda; Stephanie M Topp; Nathan Kapata; Helen Ayles; Chisela Chileshe; German Henostroza; Stewart E Reid
Journal:  Bull World Health Organ       Date:  2015-02-01       Impact factor: 9.408

4.  Determinants of Pulmonary Tuberculosis among Inmates at Mangaung Maximum Correctional Facility in Bloemfontein, South Africa.

Authors:  Peter Nyasulu; Serame Mogoere; Teye Umanah; Geoffrey Setswe
Journal:  Tuberc Res Treat       Date:  2015-03-17

5.  A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.

Authors:  Valerie Flore Donkeng-Donfack; Jules Brice Tchatchueng-Mbougua; Ngu Njei Abanda; Suzanne Magloire Ongboulal; Yvonne Josiane Djieugoue; Yannick Kamdem Simo; Micheline Mekemnang Tchoupa; Frédéric Bekang Angui; Albert Kuate Kuate; Vincent Mbassa; Edwige Mvondo Abeng Belinga; Sara Eyangoh
Journal:  BMC Infect Dis       Date:  2022-03-04       Impact factor: 3.090

6.  Health and healthcare access among Zambia's female prisoners: a health systems analysis.

Authors:  Stephanie M Topp; Clement N Moonga; Constance Mudenda; Nkandu Luo; Michael Kaingu; Chisela Chileshe; George Magwende; Jody S Heymann; German Henostroza
Journal:  Int J Equity Health       Date:  2016-09-26

7.  Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo.

Authors:  Michel Kaswa Kayomo; Epco Hasker; Muriel Aloni; Léontine Nkuku; Marcel Kazadi; Thierry Kabengele; Dorcas Muteteke; François Kapita; Alphonse Lufulwabo; Ya Diul Mukadi; Jean-Jacques Muyembe-Tamfum; Margareta Ieven; Bouke C de Jong; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.